ESR1 and cancer: BC is a heterogeneous illness on the molecular level, with molecular features such as activation of human epidermal growth factor receptor 2 (HER2), activation of hormone receptors like ER and progesterone (PR), and/or breast cancer gene (BRCA) mutations [12].